Midgard Science

BioDlink

Jiangsu, Chinabiodlink.comFrom their website, Nov 2026

  • GMP

Work here? Claim this listing

About

BioDlink is a CDMO specializing in biologics and bioconjugates, including ADCs/XDCs, with headquarters in Suzhou and centers in Shanghai and Beijing. It provides end-to-end services from early R&D through commercial manufacturing for global clients.

Services

  • ADC R&D Service Platform

    Provides one-stop ADC R&D sample preparation and druggability study services from molecular screening to preclinical candidate compound stage.

  • ADC R&D Service Platform analysis

    Offers tailored analysis and testing services for ADC molecules, including DAR, purity, free drug, concentration, and endotoxin testing.

  • ADC Process Development and Optimization

    Develops and optimizes conjugation processes for ADCs and related bioconjugates.

  • Drug Product Formulation and Lyophilization

    Develops drug product formulations and lyophilization processes for ADC and protein/antibody programs.

  • Analysis Services

    Provides analytical method development, validation, transfer, release testing, stability, structural characterization, and biosimilarity/comparability studies for biologics and ADCs.

  • Antibody Manufacturing

    Manufactures antibody drug substance and drug products at commercial scale.

    CDMO: development & manufacturing

  • ADC Drug Substance Manufacturing

    Manufactures ADC drug substance at commercial scale.

    CDMO: development & manufacturing

  • Lyophilized Drug Product Manufacture

    Manufactures lyophilized ADC and antibody drug products.

    CDMO: development & manufacturing

8 more services
  • Protein/Antibody Platform
  • Cell Culture Process Development
  • Purification Process Development
  • GMP Manufacturing
  • Technology Transfer
  • Quality Control
  • Quality Assurance
  • Regulatory Affairs
Turnaround
  • 1-3 weeks
  • 2-5 weeks
  • One Week TAT for the marketed product conjugation types
What to send
  • Tel
  • Sample Preparation Quantity
  • Conjugation Method
  • DAR Value
  • Large Molecular Type
  • Small Molecule Type
  • Estimated Demand Time

Capabilities

Assays and studies
  • ADCs
  • Antibodies
  • Process development
  • Lyophilization
  • Analytical development
  • Small molecules
19 more
  • Bispecifics
  • HPLC
  • LC-MS/MS
  • Peptides
  • DAR (RP-HPLC, HIC-HPLC, LC-MS)
  • Purity (SEC)
  • Free drug (RP-HPLC)
  • Concentration (UV)
  • Endotoxin
  • Cell-based activity assay
  • Structural characterization
  • Higher order structure analysis
  • Charge variants analysis
  • Biosimilar similarity study
  • Comparability study
  • ADCC
  • CDC
  • ADCP
  • Reporter gene assay
Scale and capacity
  • Total manufacturing capacity exceeded 20,000 L
  • 200 L bioreactors
  • 500 L bioreactors
  • 2,000 L bioreactors
  • Four commercial manufacturing lines
  • Large-scale sterile fill-finish capabilities

Instruments and platforms

  • RP-HPLC
  • HIC-HPLC
  • LC-MS
  • SEC
  • UV
  • CE-SDS
  • IEC
  • iCIEF
  • CZE
  • SPR
  • BLI
  • CD
  • DSC
  • SEC-MALS
  • AUC

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
  • Peptide
  • Recombinant protein
  • Biosimilar

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Type
CRDMO
Founded
2010
Office
120 Changyang Street,Suzhou Industrial Park,Suzhou, PRC
Sites
Suzhou, China · Shanghai, China · Beijing, China
Serves
China, Indonesia, Nigeria, Pakistan, Colombia, Bolivia, Japan

Similar labs